| abstract |
The present invention relates to an oral composition having an enhanced solubility of an alkyl galactoside while holding an inhibiting effect on coaggregation of the alkyl galactoside well. n The present invention provides an oral composition comprising the following components: (A) 0.001 mass % or more and 1 mass % or less of a compound represented by the following formula (I): n n n n n n n n n n wherein R is an optionally substituted linear or branched alkyl group having 8 to 18 carbon atoms, G is a galactose residue, E is a hydrogen atom or a methyl group, m is an integer of 0 to 200, and n is an integer of 1 to 30; (B) 0.001 mass % or more and 0.1 mass % or less of a cationic bactericide; and (C) 35 mass % or more of water. |